Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction

NAActive, not recruitingINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

August 23, 2018

Primary Completion Date

March 26, 2021

Study Completion Date

February 28, 2026

Conditions
Heart FailureCardiomyopathy, Dilated
Interventions
DEVICE

AccuCinch® Ventricular Restoration

AccuCinch® Ventricular Restoration System in Patients with Heart Failure and Reduced Ejection Fraction (HFrEF)

Trial Locations (18)

10029

Mt. Sinai, New York

10032

Columbia University Medical Center/NYPH, New York

10467

Montefiore Medical Center, The Bronx

17033

Penn State Health Milton S. Hershey Medical Center, Hershey

17101

Pinnacle Health Cardiovascular Institute, Harrisburg

19104

University of Pennsylvania, Philadelphia

22908

University of Virginia School of Medicine, Charlottesville

24014

Carilion Roanoke Memorial, Roanoke

30308

Emory University Hospital Midtown, Atlanta

40202

University of Louisville, Louisville

45219

The Christ Hospital, Cincinnati

55407

Minneapolis Heart Foundation Institute, Minneapolis

68526

Nebraska Heart Institute / Nebraska Heart Hospital, Lincoln

70360

Cardiovascular Institute of the South, Houma

77020

Baylor College of Medicine St. Luke's Medical Center, Houston

84109

Intermountain Medical Center, Salt Lake City

94143

University of California, San Francisco, San Francisco

07601

Hackensack University Medical Center, Hackensack

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Ancora Heart, Inc.

INDUSTRY

NCT03533517 - Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction | Biotech Hunter | Biotech Hunter